Evidence – Precision by Design: Accelerating Oncology Drug Discovery with High-Fidelity Models
8:10 am - Wednesday 2nd December 2026
- Leveraging integrated in vitro, in vivo, and translational approaches to better capture clinically relevant tumour biology and immune responses during drug discovery
- Understanding the strengths and limitations of different model platforms
- Evaluating how high-fidelity model systems can improve confidence in candidate selection and development decisions
